Evaluation of lung inflammation using Exhaled breath condensate in patients with post-COVID syndrome.
A. Portacci (Bari, Italy), P. Pierucci (Bari, Italy), S. Quaranta (Bari, Italy), I. Iorillo (Bari, Italy), C. Locorotondo (Bari, Italy), E. Buonamico (Bari, Italy), F. Diaferia (Bari, Italy), E. Boniello (Bari, Italy), G. Di Gioia (Bari, Italy), M. Grimaldi (Bari, Italy), G. Carpagnano (Bari, Italy)
Source: International Congress 2022 – Respiratory inflammation and the pulmonary consequences of COVID-19
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Portacci (Bari, Italy), P. Pierucci (Bari, Italy), S. Quaranta (Bari, Italy), I. Iorillo (Bari, Italy), C. Locorotondo (Bari, Italy), E. Buonamico (Bari, Italy), F. Diaferia (Bari, Italy), E. Boniello (Bari, Italy), G. Di Gioia (Bari, Italy), M. Grimaldi (Bari, Italy), G. Carpagnano (Bari, Italy). Evaluation of lung inflammation using Exhaled breath condensate in patients with post-COVID syndrome.. 4284
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|